STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2020

STOCKHOLDERS' EQUITY

Schedule of BSM using weighted-average assumptions

These fair values were derived using the BSM with the following weighted-average assumptions:

	For the Years Ended December 31,
	2020		2019
Average risk-free interest rate	0.40	%	1.84	%
Expected dividend yield	0.00	%	0.00	%
Expected lives	5.04 years		5.25 years
Expected volatility	79.75	%	68.0	%

Schedule of transaction and other information relating to stock options

Transactions and other information relating to stock options for the years December 31, 2020 and 2019 are summarized below:

				Weighted-
				Average
		Weighted-		Remaining
	Number	Average		Contractual	Aggregate
	of	Exercise		Term	Intrinsic
	Options	Price		(In Years)	Value
Outstanding at December 31, 2018	3,569,000	$	2.12	7.19	$	130,000
Grants	653,000	$	2.17
Exercised	15,000	$	1.90
Forfeited/cancelled/expired/settled	(10,000)	$	1.90
Outstanding at December 31, 2019	4,197,000	$	2.13	6.70	$	255,000
Grants	879,000	$	1.83
Exercised	1,033,000	$	1.91
Forfeited/cancelled/expired/settled	(24,000)	$	3.17
Outstanding at December 31, 2020	4,019,000	$	2.11	6.48	$	41,000
Vested and expected to vest at December 31, 2020	3,980,000	$	2.12	6.45	$	41,000
Unvested at December 31, 2020	884,000	$	1.83	9.47	$	7,000
Exercisable at December 31, 2020	3,135,000	$	2.19	5.64	$	34,000

Schedule of transaction and other information relating to restricted stock grants

Transactions and other information relating to restricted stock grants for the years ended December 31, 2020 and 2019 are summarized below:

		Average
		Fair
		Value at
		Grant
	Shares	Date
Unvested at December 31, 2018	2,124,000	$	1.85
Grants	2,604,000	$	2.16
Vested	(2,840,000)	$	1.94
Forfeited/cancelled/expired	(74,000)	$	2.19
Unvested at December 31, 2019	1,814,000	$	2.14
Grants	1,649,000	$	0.77
Vested	(1,739,000)	$	2.14
Forfeited/cancelled/expired	—	$	—
Unvested at December 31, 2020	1,724,000	$	0.83